{"organizations": [], "uuid": "239f02fbe66fd494f4e4c7811310471ea1c5d685", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180503.html", "section_title": "Archive News &amp; Video for Thursday, 03 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/bayer-covestro-sale/bayer-to-sell-further-covestro-stake-for-2-2-bln-eur-idUSFWN1SA17T", "country": "US", "domain_rank": 408, "title": "Bayer to sell further Covestro stake for 2.2 bln eur", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.464, "site_type": "news", "published": "2018-05-03T23:55:00.000+03:00", "replies_count": 0, "uuid": "239f02fbe66fd494f4e4c7811310471ea1c5d685"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/bayer-covestro-sale/bayer-to-sell-further-covestro-stake-for-2-2-bln-eur-idUSFWN1SA17T", "ord_in_thread": 0, "title": "Bayer to sell further Covestro stake for 2.2 bln eur", "locations": [], "entities": {"persons": [{"name": "covestro", "sentiment": "negative"}, {"name": "alexandra hudson our", "sentiment": "none"}, {"name": "victoria bryan editing", "sentiment": "none"}], "locations": [{"name": "berlin", "sentiment": "none"}, {"name": "covestro", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}, {"name": "j.p. morgan", "sentiment": "none"}, {"name": "bofa merrill lynch", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "BERLIN, May 3 (Reuters) - Pharmaceutical group Bayer is selling a further stake in Covestro, placing a holding of around 14.2 percent via an accelerated bookbuilding process.\nThe sale of around 29 million shares to institutional investors is set to bring proceeds of about 2.2 billion euros, Bayer said on Thursday.\nBofA Merrill Lynch and J.P. Morgan are acting as joint bookrunners.\nReporting by Victoria Bryan Editing by Alexandra Hudson\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-03T23:55:00.000+03:00", "crawled": "2018-05-04T16:47:33.063+03:00", "highlightTitle": ""}